The East African country’s campaign to end cervical cancer through the HPV vaccine has had to overcome cultural taboos and rumours about infertility – but it’s saving lives

Quick Read

Paul Ndebele, alum of our Fogarty African Bioethics Training Program, writes, “There has been significant growth in international collaborative research implemented in Sub-Saharan Africa over the past three decades… This growth has in part led to debates about the ethics of some of the research.”

Quick Read

The pharmaceutical giant Merck & Co. Inc. is ending a long-term agreement to supply a lifesaving vaccine for children in West Africa. At the same time, the company has started sending the vaccine to China, where it will likely be sold for a much higher price

Quick Read

It was a typical yet astonishing scene in Wandi village in Nigeria: a traditional barber known as a wanzam ceremonially shaved Abubakar Nafisatu’s hair on his 7th day of life, as is the custom there. Then the barber did something not so customary: He stressed to Abukabar’s mother the importance of routine immunization

Quick Read

A 60-year-old antifungal drug called flucytosine that should cost a few dollars a day but is now vastly more expensive than that

Quick Read

The Johns Hopkins-Fogarty African Bioethics Training Program (FABTP) aims to improve bioethics capacity development for institutions within Africa

Quick Read

China is making a bid to use its Ebola vaccine in the Democratic Republic of the Congo. It’s a move that could further complicate efforts to test a crowded field of vaccines and therapies in the context of a waning outbreak

Quick Read

Fortunately, the new outbreak is happening in the DRC, a country well versed in fighting the dreaded virus

Quick Read